Literature DB >> 14632188

A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.

Guofang Hu1, Meltem Onder, Melissa Gill, Burhan Aksakal, Murat Oztas, M Ali Gürer, Jülide Tok Celebi.   

Abstract

Brooke-Spiegler syndrome (BSS, familial cylindromatosis or turban tumor syndrome) is an inherited disease characterized by neoplasms of the skin appendages such as cylindroma, trichoepithelioma, and spiradenoma. The disease has been mapped to 16q12-13, and mutations in the CYLD gene have been identified in families with this disorder. Of interest, multiple familial trichoepithelioma (MFT) has been described as a distinct disorder characterized by the familial occurrence of trichoepitheliomas. MFT has been mapped to 9p21; however, to date a candidate gene has not been identified. In this report, we describe a four-generation family with BSS presenting predominantly with trichoepitheliomas (resembling MFT phenotype). We identified a novel missense mutation in the CYLD gene, designated E474G, in the affected individuals of this family. Our findings exemplify clinical heterogeneity within BSS and extend the body of evidence that mutations in CYLD are implicated in this disease. Although not conclusive, these findings suggest that BSS and MFT may represent a single entity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632188     DOI: 10.1046/j.1523-1747.2003.12514.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.

Authors:  Atsushi Uematsu; Kohki Kido; Hirotaka Takahashi; Chikako Takahashi; Yuta Yanagihara; Noritaka Saeki; Shuhei Yoshida; Masashi Maekawa; Mamoru Honda; Tsutomu Kai; Kouhei Shimizu; Shigeki Higashiyama; Yuuki Imai; Fuminori Tokunaga; Tatsuya Sawasaki
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

Review 2.  Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.

Authors:  Axel Witt; Domagoj Vucic
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

3.  Brooke-spiegler syndrome: a rare entity.

Authors:  Kajal Manchanda; Manish Bansal; Aakash Amar Bhayana; Ss Pandey
Journal:  Int J Trichology       Date:  2012-01

Review 4.  Genetics of skin appendage neoplasms and related syndromes.

Authors:  D A Lee; M E Grossman; P Schneiderman; J T Celebi
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

5.  [Multiple familiar trichoepithelioma (Brooke's syndrome) : A rare autosomal dermatosis with possible periocular manifestation].

Authors:  F Rensch; B Harder; M Goebeler; W Back; J B Jonas; F Schlichtenbrede
Journal:  Ophthalmologe       Date:  2009-08       Impact factor: 1.059

Review 6.  Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.

Authors:  Patrick W Blake; Jorge R Toro
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

7.  The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene.

Authors:  Katalin Farkas; Barbara Kocsis Deák; Laura Cubells Sánchez; Ana Mercedes Victoria Martínez; Juan José Vilata Corell; Alfredo Montoro Botella; Goitzane Marcaida Benito; Raquel Rodríguez López; Tomas Vanecek; Dmitry V Kazakov; Joan N R Kromosoeto; Ans M W van den Ouweland; János Varga; Márta Széll; Nikoletta Nagy
Journal:  BMC Genet       Date:  2016-02-09       Impact factor: 2.797

8.  Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.

Authors:  Neil Rajan; James A A Langtry; Alan Ashworth; Catherine Roberts; Pam Chapman; John Burn; Alison H Trainer
Journal:  Arch Dermatol       Date:  2009-11

9.  Brooke-spiegler syndrome: a rare entity.

Authors:  Monika Rathi; Seema Awasthi; Satish Kumar Budania; Faiyaz Ahmad; Shyamoli Dutta; Ashutosh Kumar
Journal:  Case Rep Pathol       Date:  2014-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.